Fresenius Medical Care AG ADR (FMS) concluded trading on Thursday at a closing price of $23.65, with 0.45 million shares of worth about $10.52 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 18.25% during that period and on April 17, 2025 the price saw a loss of about -4.44%. Currently the company’s common shares owned by public are about 586.83M shares, out of which, 586.39M shares are available for trading.
Stock saw a price change of -0.71% in past 5 days and over the past one month there was a price change of -4.56%. Year-to-date (YTD), FMS shares are showing a performance of 4.46% which increased to 27.15% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $17.93 but also hit the highest price of $25.96 during that period. The average intraday trading volume for Fresenius Medical Care AG ADR shares is 323.19K. The stock is currently trading -2.61% below its 20-day simple moving average (SMA20), while that difference is down -1.56% for SMA50 and it goes to 8.18% higher than SMA200.
Fresenius Medical Care AG ADR (NYSE: FMS) currently have 586.83M outstanding shares and institutions hold larger chunk of about 5.81% of that.
The stock has a current market capitalization of $13.88B and its 3Y-monthly beta is at 0.82. PE ratio of stock for trailing 12 months is 23.77, while it has posted earnings per share of $0.99 in the same period. Its PEG reads 1.54 and has Quick Ratio of 0.99 while making debt-to-equity ratio of 0.75. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for FMS, volatility over the week remained 1.60% while standing at 2.28% over the month.
Stock’s fiscal year EPS is expected to rise by 23.18% while it is estimated to increase by 12.44% in next year. EPS is likely to grow at an annualized rate of 15.41% for next 5-years, compared to annual growth of -14.87% made by the stock over the past 5-years.
Coverage by Berenberg stated Fresenius Medical Care AG ADR (FMS) stock as a Buy in their note to investors on November 06, 2024, suggesting a price target of $25.60 for the stock. Stock get a Buy rating from Societe Generale on November 17, 2023.
